- Trials with a EudraCT protocol (227)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (9)

These are paediatric studies completed by 26 January 2007, in respect of products authorised in the Community (Article 45 of the Paediatric Regulation (EC) No 1901/2006). | |
Note: Advanced search filters for country, trial phase, gender, rare disease, IMP with orphan designation in the indication and age ranges of in-utero, adult or elderly do not apply to these records. |
Study title: A Phase III, Prospective, Placebo-Controlled, Double-Blinded, Randomized, Multi-Center Study to Determine the Safety and Efficacy of Calcijex® (Calcitriol Injection) in Decreasing Serum Intact Parathyroid Hormone Levels in Pediatric End Stage Renal Disease Patients on Hemodialysis |
Active substance: CALCITRIOL |
Study summary document link (including results): Calcitriol-1999007.pdf |
View full study record |
Document reference: 47097 |
Study title: Salusky IB, Goodman WG, Sahney S, Gales B, Perilloux A, Wang HJ, Elashoff RM, Jüppner H. Sevelamer controls parathyroid hormone-induced bone disease as efficiently as calcium carbonate without increasing serum calcium levels during therapy with active vitamin D sterols. J Am Soc Nephrol. 2005 Aug; 16(8):2501-8. Epub 2005 Jun 8. Salusky IB, Goodman WG, Sahney S, Gales B, Perilloux A, Wang HJ, Elashoff RM, Jüppner H. Sevelamer controls parathyroid hormone-induced bone disease as efficiently as calcium carbonate without increasing serum calcium levels during therapy with active vitamin D sterols. J Am Soc Nephrol. 2005 Aug; 16(8):2501-8. Epub 2005 Jun 8. |
Active substance: CALCIUM CARBONATE |
Study summary document link (including results): |
View full study record |
Document reference: 23163 |
Study title: Prevalence of goitre and hypothyroidism in Southern Tanzania: Effect of iodised oil on thyroid hormone deficiency. |
Active substance: Ethyl esters of iodized fatty acids of poppy seed oil |
Study summary document link (including results): |
View full study record |
Document reference: 39970 |
Study title: Effect of oral iodized oil on thyroid size and thyroid hormone metabolism in children with concurrent selenium and iodine deficiency. ; Zimmermann-M-B. European Journal of Clinical Nutrition, 2000, Vol /Iss/Pg. 54/3 (209-213)Effect of oral iodized oil on thyroid size and thyroid hormone metabolism in children with concurrent selenium and iodine deficiency. ; Zimmermann-M-B. European Journal of Clinical Nutrition, 2000, Vol /Iss/Pg. 54/3 (209-213) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30234 |
Study title: Prevalence of goitre and hypothyroidism in Southern Tanzania: Effect of iodised oil on thyroid hormone deficiency. ; Wachter-W. Journal of Epidemiology and Community Health, 1986, Vol/Iss/Pg. 40/1 (86-91)Prevalence of goitre and hypothyroidism in Southern Tanzania: Effect of iodised oil on thyroid hormone deficiency. ; Wachter-W. Journal of Epidemiology and Community Health, 1986, Vol/Iss/Pg. 40/1 (86-91) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30311 |
Study title: Influence of timing and dose of thyroid hormone replacement on development in infants with congenital hypothyroidismJ Pediatr 2000; 136: 292-297 Bongers-Schokking JJ., 2000 |
Active substance: LEVOTHYROXINE |
Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
View full study record |
Document reference: 48982 |
Study title: A Phase IV, Double-Blind, Placebo-Controlled, Multi-Center Study to Determine the Safety and Effectiveness of Zemplar in Decreasing Serum Intact Parathyroid Hormone Levels in Pediatric End Stage Renal Disease Subjects on Hemodialysis |
Active substance: PARICALCITOL |
Study summary document link (including results): Paricalcitol-2001022.pdf |
View full study record |
Document reference: 45819 |
Study title: Colls F. et.al, Changes in plasma thyroid hormones levels after a single dose of triiodothyronine in prmature infants of less than 30 weeks gestational age, Eur. J. Endocrinology 143, 733-740, 2000 |
Active substance: LIOTHYRONINE |
Study summary document link (including results): |
View full study record |
Document reference: 47215 |
Study title: Aktas A, Elahi N. Bone scan findings in patients with chronic renal failure having symptoms related to bone: correlation with parathyroid hormone levels. Transplant Proc. 1999 Dec;31(8):3309-11. No abstract available. Aktas A, Elahi N. Bone scan findings in patients with chronic renal failure having symptoms related to bone: correlation with parathyroid hormone levels. Transplant Proc. 1999 Dec;31(8):3309-11. No abstract available. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43498 |